wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33625574-3018357C-D449-42D8-BACC-8DC02255BA32
Q33625574-3018357C-D449-42D8-BACC-8DC02255BA32
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33625574-3018357C-D449-42D8-BACC-8DC02255BA32
PCSK9 inhibitor access barriers-issues and recommendations: Improving the access process for patients, clinicians and payers.
P2860
Q33625574-3018357C-D449-42D8-BACC-8DC02255BA32
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33625574-3018357C-D449-42D8-BACC-8DC02255BA32
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2f6156d65b94b228bce2172dca85088cf6ec0a6d
P2860
Efficacy and safety of longer-term administration of evolocumab (AMG 145) in patients with hypercholesterolemia: 52-week results from the Open-Label Study of Long-Term Evaluation Against LDL-C (OSLER) randomized trial.